Related Experiment Videos
[Implantable infusion devices. Experience of 360 cases]
J P Chevrel1, M D Destable, J L Breau
1Service de Chirurgie générale et digestive, Hôpital Avicenne, Université Paris XIII, Bobigny.
Presse Medicale (Paris, France : 1983)
|January 9, 1988
Summary
Implantable infusion devices, primarily Port A Cath systems, were used for chemotherapy between 1983-1986. Thrombosis and infection were the main complications, necessitating careful placement and radiography to minimize risks.
Area of Science:
- Oncology
- Medical Devices
- Surgical Procedures
Context:
- Systemic chemotherapy administration
- Implantable infusion devices (Port A Cath systems)
- 1983-1986 study period
Purpose:
- Evaluate complications of implantable infusion devices for chemotherapy
- Assess the efficacy of Port A Cath systems
- Analyze thrombosis and infection rates
Summary:
- 360 devices inserted for chemotherapy; Port A Cath systems were most common.
- Observed complications: thrombosis (5%) and infection (2.2%).
- Subclavian vein puncture and intra-operative radiography recommended to reduce malposition and thrombosis risks.
Impact:
- Highlights the importance of proper technique and imaging for device safety.
- Informs clinical practice regarding the use of implantable infusion devices in chemotherapy.
- Provides data on complication rates for long-term chemotherapy delivery systems.